Ankur Varma

911 total citations
34 papers, 495 citations indexed

About

Ankur Varma is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Ankur Varma has authored 34 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 12 papers in Oncology and 8 papers in Genetics. Recurrent topics in Ankur Varma's work include Acute Myeloid Leukemia Research (9 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ankur Varma is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ankur Varma collaborates with scholars based in United States, India and United Kingdom. Ankur Varma's co-authors include Vicente Valero, Richard E. Champlin, Gabriela Rondón, Samer A. Srour, Rima M. Saliba, Stefan O. Ciurea, Julianne Chen, Erik P. Sulman, Debu Tripathy and Partow Kebriaei and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Ankur Varma

30 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ankur Varma United States 12 257 123 109 76 76 34 495
Francesco Grimaldi Italy 11 121 0.5× 167 1.4× 71 0.7× 55 0.7× 74 1.0× 29 470
Konstantin Schlick Austria 15 255 1.0× 111 0.9× 83 0.8× 106 1.4× 78 1.0× 35 526
Anna Pawłowska United States 11 95 0.4× 125 1.0× 63 0.6× 124 1.6× 65 0.9× 44 465
Muhamad Alhaj Moustafa United States 10 121 0.5× 88 0.7× 50 0.5× 50 0.7× 79 1.0× 89 315
Bicky Thapa United States 13 244 0.9× 89 0.7× 91 0.8× 101 1.3× 67 0.9× 51 441
Man Updesh Singh Sachdeva India 13 101 0.4× 245 2.0× 54 0.5× 107 1.4× 185 2.4× 118 648
Jessica Hochberg United States 14 279 1.1× 92 0.7× 50 0.5× 76 1.0× 58 0.8× 43 552
Meerim Park South Korea 16 119 0.5× 191 1.6× 78 0.7× 90 1.2× 66 0.9× 49 521
Hamid Ehsan United States 10 116 0.5× 87 0.7× 101 0.9× 67 0.9× 36 0.5× 46 341
Gabrielle Meyers United States 15 124 0.5× 334 2.7× 41 0.4× 85 1.1× 169 2.2× 43 602

Countries citing papers authored by Ankur Varma

Since Specialization
Citations

This map shows the geographic impact of Ankur Varma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankur Varma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankur Varma more than expected).

Fields of papers citing papers by Ankur Varma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankur Varma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankur Varma. The network helps show where Ankur Varma may publish in the future.

Co-authorship network of co-authors of Ankur Varma

This figure shows the co-authorship network connecting the top 25 collaborators of Ankur Varma. A scholar is included among the top collaborators of Ankur Varma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankur Varma. Ankur Varma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Sunny, et al.. (2025). Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature. Diagnostics. 15(14). 1835–1835.
2.
Harbaugh, Brent K., et al.. (2025). Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances. Cancers. 17(3). 508–508.
3.
Varma, Ankur, et al.. (2023). Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity. Cancers. 15(21). 5149–5149. 15 indexed citations
4.
5.
6.
Varma, Ankur, et al.. (2022). Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. Transplant Immunology. 76. 101742–101742. 1 indexed citations
7.
Shah, Mithun Vinod, Rima M. Saliba, Ankur Varma, et al.. (2021). Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era. British Journal of Haematology. 193(5). 1004–1008. 8 indexed citations
8.
Rhee, Yoona, Carlos Santos, Nell S. Lurain, et al.. (2020). Difficult Balance Between Multidrug-Resistant Cytomegalovirus Infection and Graft-Versus-Host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient. Infectious Diseases in Clinical Practice. 28(5). 257–260.
9.
Varma, Ankur, Gabriela Rondón, Samer A. Srour, et al.. (2020). Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(5). 1013–1020. 39 indexed citations
10.
Strati, Paolo, Ankur Varma, Sherry Adkins, et al.. (2020). Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica. 106(10). 2667–2672. 94 indexed citations
11.
Ciurea, Stefan O., Piyanuch Kongtim, Ankur Varma, et al.. (2019). Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?. Blood. 135(6). 449–452. 28 indexed citations
12.
Kongtim, Piyanuch, Omar Hasan, Ankur Varma, et al.. (2019). Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(1). 197–203. 15 indexed citations
13.
Strati, Paolo, Sherry Adkins, Loretta J. Nastoupil, et al.. (2019). Hematopoietic recovery and immune reconstitution after axi-cel CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.. Journal of Clinical Oncology. 37(15_suppl). 7545–7545. 8 indexed citations
14.
Afrough, Aimaz, Rima M. Saliba, Amir Hamdi, et al.. (2018). Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(11). 2197–2203. 18 indexed citations
15.
Varma, Ankur, Rima M. Saliba, Harrys A. Torres, et al.. (2016). Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. Bone Marrow Transplantation. 51(7). 999–1001. 6 indexed citations
16.
Afrough, Aimaz, Rima M. Saliba, Amir Hamdi, et al.. (2015). Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(8). 1413–1417. 5 indexed citations
17.
Murthy, Rashmi K., Ankur Varma, Kenneth R. Hess, et al.. (2014). Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer. Cancer. 120(13). 1932–1938. 33 indexed citations
18.
Varma, Ankur, et al.. (2010). Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India. Nephrology Dialysis Transplantation. 25(9). 3011–3017. 53 indexed citations
19.
Varma, Ankur, et al.. (2002). The effect of antidepressants on serum melatonin levels in endogenous depression.. PubMed. 50. 1262–5. 6 indexed citations
20.
Varma, Ankur, et al.. (1998). Trichobezoar with small bowel obstruction. The Indian Journal of Pediatrics. 65(5). 761–763. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Grimaldi Breakdown of academic impact, for papers by Konstantin Schlick Breakdown of academic impact, for papers by Anna Pawłowska Breakdown of academic impact, for papers by Muhamad Alhaj Moustafa Breakdown of academic impact, for papers by Bicky Thapa Breakdown of academic impact, for papers by Man Updesh Singh Sachdeva Breakdown of academic impact, for papers by Jessica Hochberg Breakdown of academic impact, for papers by Meerim Park Breakdown of academic impact, for papers by Hamid Ehsan Breakdown of academic impact, for papers by Gabrielle Meyers
Rankless by CCL
2026